Workflow
P&G(PG)
icon
Search documents
I Predicted Coca-Cola Was a Better Buy Than Procter & Gamble in 2025, and I Was Right. Here Is My New Prediction for 2026.
The Motley Fool· 2026-01-21 03:15
Core Insights - Coca-Cola outperformed Procter & Gamble in 2025, with a gain of 12.3% compared to a 14.5% decline for P&G, despite the consumer staples sector being the worst-performing sector that year [1][2] - Both companies are recognized for their long histories of dividend increases, with Coca-Cola having 63 consecutive years and Procter & Gamble 69 years [3] Company Performance - Coca-Cola's strong performance is attributed to its robust supply chain and high margins, supported by a network of bottling partners that enhance operational flexibility [4] - Procter & Gamble also maintains high margins due to its size and brand portfolio, allowing both companies to convert more revenue into operating income than their peers [5] Capital Allocation Strategies - Coca-Cola has focused on mergers and acquisitions to diversify its brand portfolio, acquiring brands like BodyArmor and Costa Coffee, while Procter & Gamble has concentrated on innovation within its existing brands [7][8] - Despite Coca-Cola's diversification, it still heavily relies on its flagship brand, which accounted for 42% of U.S. unit case volume in 2024 [8] Revenue Growth Projections - For 2025, Coca-Cola is guiding for non-GAAP organic revenue growth of 5% to 6%, while Procter & Gamble's organic sales growth was only 2% for fiscal 2025, with a guidance of 0% to 4% for fiscal 2026 [9] Valuation and Investment Outlook - Heading into 2025, Coca-Cola was considered a better value due to its high margins and ability to maintain volume, while the narrative has shifted for 2026, making Procter & Gamble the better value [11][12] - Both stocks are trading below their historical valuations, making them attractive options for income investors looking to enhance passive income streams [13]
Can PG's Productivity Drive Fuel EPS Gains Amid Inflation?
ZACKS· 2026-01-20 18:36
Core Insights - Procter & Gamble (PG) is focusing on productivity as a key driver for earnings growth amidst ongoing inflationary pressures in raw materials, logistics, and labor [1][3] - The company is implementing cost savings, supply-chain efficiencies, and organizational simplification to protect profitability, rather than relying solely on pricing [1][2] - This productivity-driven strategy aims to offset inflation and create opportunities for reinvestment in innovation and brand support, which are essential for PG's long-term growth [1][2] Productivity Initiatives - PG's productivity initiatives include manufacturing optimization, procurement efficiencies, and structural cost reductions, which are part of a multi-year cost savings program [2] - These efforts have stabilized operating margins and supported earnings per share (EPS) growth despite elevated input costs [2] - By simplifying product portfolios and improving demand forecasting, PG is converting efficiency gains into earnings resilience [2] Long-term Sustainability - The sustainability of PG's productivity gains is crucial for long-term earnings growth, which relies on volume recovery and successful innovation [3] - If PG can effectively reinvest efficiency gains without impairing execution, its productivity engine may continue to drive EPS growth [3] - In a market where pricing power is normalizing, PG's ability to self-fund growth through productivity could be vital for maintaining earnings momentum [3] Industry Comparisons - Other companies like Church & Dwight (CHD) and Colgate-Palmolive (CL) are also leveraging productivity-driven efficiency gains to protect earnings amid inflation [4][5][6] - CHD is focusing on manufacturing efficiencies and disciplined cost control to expand adjusted gross margins while investing in brand marketing [5] - CL is utilizing productivity programs to offset inflation and currency pressures, with a focus on reinvesting savings into brand building and innovation [6] Financial Performance - PG's shares have declined approximately 6.7% over the past six months, compared to an 8.4% decline in the industry [7] - The company has a forward price-to-earnings ratio of 20.17, higher than the industry average of 18.19 [9] - The Zacks Consensus Estimate indicates a year-over-year EPS growth of 2.1% for fiscal 2026 and 5% for fiscal 2027, although recent estimates have been revised downward [10]
[DowJonesToday]Dow Jones Plunges Amid Geopolitical Tensions Over Greenland Tariff Threats
Stock Market News· 2026-01-20 16:09
Market Overview - The Dow Jones Industrial Average declined by 559.24 points (-1.13%) on January 20th, 2026, due to escalating geopolitical tensions and the threat of new tariffs from President Trump on eight NATO allies [1] - Investor confidence was shaken, leading to a sell-off in equities and a shift towards safe-haven assets like gold and silver [1] Company Performance - Technology and industrial stocks were significantly affected, with 3M Company (MMM) experiencing the largest drop at -6.50%, influenced by post-earnings movements [2] - IBM (IBM) also faced a notable decline of -4.47%, while Nvidia (NVDA) and Amazon (AMZN) fell by -2.57% and -1.77% respectively, indicating a broader sell-off among major tech firms [2] Resilient Stocks - Despite the overall market downturn, some Dow components showed gains, with UnitedHealth Group (UNH) rising by +1.05% [3] - Travelers Companies (TRV) increased by +0.71%, and Procter & Gamble (PG) gained +0.70%, demonstrating resilience in a challenging market [3] - Boeing (BA) and Nike (NKE) also recorded modest increases of +0.14% each, highlighting pockets of strength amidst the decline [3]
Jim Cramer on Procter & Gamble’s Earnings: “I Don’t Expect Any Fireworks or Anything”
Yahoo Finance· 2026-01-20 16:02
Group 1 - Procter & Gamble (NYSE: PG) is included in Jim Cramer's Charitable Trust portfolio due to its new CEO and strong brand recognition, despite recent negative pre-announcements [1] - The company operates in the consumer goods sector, offering products in beauty, grooming, health care, home care, and family care, with well-known brands like Tide, Pampers, Gillette, Crest, Olay, and Febreze [2] - Cramer noted that even with anticipated poor performance, Procter & Gamble is expected to perform better than cyclical stocks during economic downturns, making it a strategic hedge for the Charitable Trust [2]
Money Supply Trends Suggest Stability Rather Than US dollar Debasement
Investing· 2026-01-20 10:47
Market Analysis by covering: Procter & Gamble Company, United Airlines Holdings Inc, Netflix Inc. Read 's Market Analysis on Investing.com ...
P&G Gets Target Hike as Barclays Calls Move a “Flight to Safety”
Yahoo Finance· 2026-01-20 01:21
Group 1: Company Overview - The Procter & Gamble Company (NYSE:PG) is recognized as one of the 13 Best Dividend Kings to buy in 2026 [1] - P&G is a global consumer products company that sells branded packaged goods across multiple categories to consumers worldwide [4] Group 2: Stock Performance and Analyst Insights - Barclays analyst Lauren Lieberman raised P&G's price target to $155 from $151, maintaining an Equal Weight rating, indicating a cautious outlook despite recent enthusiasm [2] - P&G's stock has declined nearly 11% over the past 12 months due to inflationary pressures and increased price sensitivity among consumers [3] - In the fiscal first quarter ending September 30, P&G reported a 2% increase in sales, with price and mix contributing 1 percentage point each to growth, while volumes remained flat [4]
Procter & Gamble Q2 Earnings Preview: Buy Now or Stay Cautious?
ZACKS· 2026-01-19 18:41
Core Viewpoint - Procter & Gamble (PG) is expected to report second-quarter fiscal 2026 results on January 22, with projected year-over-year sales growth of 1.6% to $22.23 billion, while earnings per share are anticipated to decline by 0.5% to $1.87 [1][2]. Financial Expectations - The Zacks Consensus Estimate for revenues is $22.23 billion, reflecting a 1.6% increase from the previous year [2]. - The earnings consensus is $1.87 per share, indicating a 0.5% decrease from the prior year [2]. - PG has a trailing four-quarter earnings surprise of 2.3% on average, with a 4.7% surprise in the first quarter of fiscal 2026 [3]. Earnings Prediction - The model indicates a negative Earnings ESP of -0.82% and a Zacks Rank of 4 (Sell), suggesting a lower likelihood of an earnings beat this quarter [4]. Operational Challenges - PG faces significant challenges, including elevated commodity costs, higher tariffs, and intense competition in developed markets, which are expected to pressure margins [6][10]. - The company anticipates a commodity cost headwind of $100 million after tax for fiscal 2026, impacting gross margins [8]. - Tariffs are projected to add $400 million in after-tax costs for fiscal 2026, further complicating earnings visibility [10][11]. Margin Outlook - A year-over-year core gross margin decline of 50 basis points is predicted, with core operating margins expected to fall by 80 basis points [9]. - The high-cost environment is likely to continue affecting gross margins in the upcoming quarter [8]. Sales Growth Projections - Organic sales growth is forecasted at 1% for the second quarter, with specific segments like Beauty and Health Care expected to grow by 2%, and Grooming by 4% [14]. - Fabric & Home Care and Baby, Feminine & Family Care segments are anticipated to remain flat year-over-year [14]. Strategic Initiatives - PG is focusing on restructuring, productivity initiatives, and innovation to navigate current challenges and improve agility [15][25]. - The company is rolling out major product upgrades and new formats to drive sustainable growth [13]. Stock Performance and Valuation - PG shares have declined by 6.7% over the past six months, underperforming the industry average decline of 8.4% [16][20]. - The stock is trading at a forward P/E multiple of 20.18X, above the industry average of 18.2X but below the S&P 500's average of 23.29X, indicating a premium valuation [21]. Investment Considerations - The investment appeal of PG lies in its strong brand portfolio and disciplined execution, despite near-term pressures from competitive intensity and input costs [24][25]. - Investors may prefer a cautious approach, monitoring execution on innovation and productivity initiatives, while existing shareholders might hold for stability [27].
3 Brilliant Dividend Stocks to Buy Now and Hold for a Lifetime of Income
Yahoo Finance· 2026-01-19 13:16
Group 1: Comfort Systems USA - Comfort Systems USA has experienced significant growth, gaining over 1,700% in the past five years, with a current dividend yield of 0.25% and a 20% increase in dividends last year [3][4] - The company reported a record backlog of $9.38 billion, reflecting a 65% year-over-year improvement, driven by increased demand for HVAC and electrical services from AI data centers [4][8] Group 2: Verizon Communications - Verizon Communications offers a high dividend yield of 7% and low volatility, making it an attractive option for risk-averse investors [5][6] - The company has maintained stable margins despite flat revenue growth, indicating improved profitability and a well-diversified customer base [5][6] Group 3: Procter & Gamble - Procter & Gamble has a strong dividend history, having paid dividends for 135 consecutive years, including 69 years of consecutive increases, with a 5% dividend raise in 2025 [9][8]
My Top Dividend Stock to Buy in January
The Motley Fool· 2026-01-18 20:15
Core Viewpoint - Dividend stocks provide a reliable source of passive income and are essential for diversifying investment strategies, especially in volatile market conditions [1]. Company Summary - Procter & Gamble (PG) is highlighted as a top dividend stock with a trailing-12-month dividend yield of approximately 2.9% [2]. - The company is classified as a Dividend King, having paid and increased its annual dividend for 69 consecutive years, indicating strong reliability in dividend payments [3]. - Procter & Gamble's free-cash-flow yield exceeds its dividend yield, with a payout ratio of about 60%, demonstrating its capacity to sustain and potentially increase dividends [5]. - The company is characterized as a mature blue-chip stock, providing essential household products that are likely to maintain demand even during economic downturns [6]. - The current market conditions favor the inclusion of stable dividend stocks like Procter & Gamble in investment portfolios, especially as interest rates may decline, enhancing the attractiveness of its nearly 3% dividend yield [7].
Trump Speech, Earnings and Other Key Things to Watch this Week
Yahoo Finance· 2026-01-18 18:00
Economic Policy and Market Impact - President Trump's upcoming speech is expected to outline economic priorities and policy initiatives, with a focus on tax policy changes, infrastructure spending, regulatory approaches, and trade policy, particularly regarding China [1][2] - The speech's timing amid earnings season and critical economic data releases creates a complex backdrop for market reactions, as political rhetoric and corporate results will compete for investor attention [1][2] Economic Data Releases - Thursday will see a significant convergence of economic data, including the Q3 GDP revision and the November Core PCE Price Index, both released at 8:30am, which could lead to market volatility as investors assess growth and inflation data simultaneously [4] - The GDP revision will provide insights into consumer spending, business investment, and net exports, while the Core PCE Price Index will be crucial for understanding inflation trends [4] Company Earnings Insights - Netflix's earnings report will be critical for understanding the streaming industry's economics, including subscriber growth sustainability and content investment returns, especially in light of competition from platforms like Disney+ and Amazon Prime Video [5] - Intel's earnings will be a key indicator of its manufacturing transformation and competitive positioning in the semiconductor market, while GE Aerospace's results will provide insights into commercial aviation demand and defense spending trends [7] - Johnson & Johnson's earnings will offer perspectives on pharmaceutical demand and healthcare spending trends, while Procter & Gamble's results will assess consumer resilience in personal care and household products [8]